New vulnerability in liver tumor cells' nuclear gateways identified for therapy

A study by the Vall d'Hebron Institute of Oncology has discovered that liver tumor cells rely on two proteins, CDK16 and CDK18, to repair DNA and sustain growth. The research, published in the Proceedings of the National Academy of Sciences, suggests that targeting both proteins could impair tumor cell survival and guide new treatment strategies.

Originally published by gnews